GLP-1 Price Cut Storm: Lilly and Novo Nordisk Engage in Strategic “Volume-for-Value” Game Nov 10, 2025 Life Science
AstraZeneca Soars on Positive Trial Results for Hypertension Drug and Strong Earnings Nov 10, 2025 Life Science
Metsera’s Impressive Clinical Data for Weight-Loss Drug Sparks Bidding War Among Pharma Giants Nov 6, 2025 Life Science
U.S. Government Facilitates Historic Price Cut for Weight-Loss Drugs, with an Agreed Price of $245 Nov 6, 2025 Life Science
Beyond the Tech Titans: An AI Stock With a Different Kind of Disruption Nov 4, 2025 Life Science, Technology
Experiments, Mergers, and Interest Rate Cuts: The Biotechnology Sector Ushers in a New Cycle Nov 4, 2025 Life Science
Metsera’s Weight-Loss Drug Technology Sparks Bidding War Among Giants as Stock Price Quadruples in a Month Nov 4, 2025 Life Science
Defensive Plays for a Bear Market: 3 Healthcare Stocks with Robust Dividends Nov 3, 2025 Life Science
Seeking Certainty in Growth Stocks: Where to Invest for 2025 Oct 30, 2025 Financial Service, Life Science, Technology
Who Will Be the Next Winner in the Weight-Loss Drug Market? BioAge Labs Attracts Attention Oct 30, 2025 Life Science
With Yields Exceeding 5%, These Two High-Dividend Stocks Are Worth Watching Oct 29, 2025 Consumer Goods, Life Science
Trump’s Price-Cutting Vow Rattles Novo Nordisk, But Valuation and Pipeline Offer Compelling Case Oct 29, 2025 Life Science
